| Expression of DNA methyltransferases in breast cancer patients and to analyze the effect of natural compounds on DNA methyltransferases and associated proteins S Mirza, G Sharma, R Parshad, SD Gupta, P Pandya, R Ralhan Journal of breast cancer 16 (1), 23-31, 2013 | 237 | 2013 |
| Promoter hypermethylation of TMS1, BRCA1, ERα and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients S Mirza, G Sharma, CP Prasad, R Parshad, A Srivastava, SD Gupta, ... Life sciences 81 (4), 280-287, 2007 | 157 | 2007 |
| Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients G Sharma, S Mirza, CP Prasad, A Srivastava, SD Gupta, R Ralhan Life sciences 80 (20), 1873-1881, 2007 | 156 | 2007 |
| 3D bioprinting of breast cancer models for drug resistance study Y Wang, W Shi, M Kuss, S Mirza, D Qi, A Krasnoslobodtsev, J Zeng, ... ACS Biomaterials Science & Engineering 4 (12), 4401-4411, 2018 | 151 | 2018 |
| Epigenetic alterations of CDH1 and APC genes: Relationship with activation of Wnt/β-catenin Pathway in invasive ductal carcinoma of breast CP Prasad, S Mirza, G Sharma, R Prashad, S DattaGupta, G Rath, ... Life sciences 83 (9-10), 318-325, 2008 | 133 | 2008 |
| Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients G Sharma, S Mirza, R Parshad, A Srivastava, SD Gupta, P Pandya, ... Life sciences 87 (3-4), 83-91, 2010 | 108 | 2010 |
| Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments G Dagar, A Gupta, T Masoodi, S Nisar, M Merhi, S Hashem, R Chauhan, ... Journal of translational medicine 21 (1), 449, 2023 | 106 | 2023 |
| CpG hypomethylation of MDR1 gene in tumor and serum of invasive ductal breast carcinoma patients G Sharma, S Mirza, R Parshad, A Srivastava, SD Gupta, P Pandya, ... Clinical biochemistry 43 (4-5), 373-379, 2010 | 96 | 2010 |
| Mouse models of estrogen receptor-positive breast cancer S Mohibi, S Mirza, H Band, V Band Journal of carcinogenesis 10, 35, 2011 | 93 | 2011 |
| Demethylating agent 5-aza-2-deoxycytidine enhances susceptibility of breast cancer cells to anticancer agents S Mirza, G Sharma, P Pandya, R Ralhan Molecular and cellular biochemistry 342, 101-109, 2010 | 93 | 2010 |
| Detection of RASSF1A and RAR? Hypermethylation in Serum DNA from Breast Cancer Patients S Shukla, S Mirza, G Sharma, R Parshad, SD Gupta, R Ralhan Epigenetics 1 (2), 88-93, 2006 | 92 | 2006 |
| 3D hydrogel breast cancer models for studying the effects of hypoxia on epithelial to mesenchymal transition Y Wang, S Mirza, S Wu, J Zeng, W Shi, H Band, V Band, B Duan Oncotarget 9 (63), 32191, 2018 | 71 | 2018 |
| DNA methylation of circulating DNA: a marker for monitoring efficacy of neoadjuvant chemotherapy in breast cancer patients G Sharma, S Mirza, R Parshad, SD Gupta, R Ralhan Tumor Biology 33, 1837-1843, 2012 | 71 | 2012 |
| Prognostic relevance of promoter hypermethylation of multiple genes in breast cancer patients G Sharma, S Mirza, YH Yang, R Parshad, P Hazrah, S Datta Gupta, ... Analytical Cellular Pathology 31 (6), 487-500, 2009 | 66 | 2009 |
| Clinical significance of Stratifin, ERα and PR promoter methylation in tumor and serum DNA in Indian breast cancer patients S Mirza, G Sharma, R Parshad, A Srivastava, SD Gupta, R Ralhan Clinical biochemistry 43 (4-5), 380-386, 2010 | 59 | 2010 |
| Clinical significance of Maspin promoter methylation and loss of its protein expression in invasive ductal breast carcinoma: correlation with VEGF-A and MTA1 … G Sharma, S Mirza, R Parshad, A Srivastava, SD Gupta, P Pandya, ... Tumor Biology 32, 23-32, 2011 | 56 | 2011 |
| Clinical Significance of Promoter Hypermethylation of ERβ and RARβ2 in Tumor and Serum DNA in Indian Breast Cancer Patients S Mirza, G Sharma, R Parshad, A Srivastava, SD Gupta, R Ralhan Annals of surgical oncology 19, 3107-3115, 2012 | 44 | 2012 |
| Loss of the nuclear pool of ubiquitin ligase CHIP/STUB1 in breast cancer unleashes the MZF1-cathepsin pro-oncogenic program H Luan, B Mohapatra, TA Bielecki, I Mushtaq, S Mirza, TA Jennings, ... Cancer research 78 (10), 2524-2535, 2018 | 43 | 2018 |
| Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast Cancer or Preinvasive Ductal Carcinoma In Situ Induces Synthetic Lethality and Chemoprevention R Ali, A Al-Kawaz, MS Toss, AR Green, IM Miligy, KA Mesquita, ... Cancer Research 78 (24), 6818-6827, 2018 | 40 | 2018 |
| Mammalian alteration/deficiency in activation 3 (Ada3) is essential for embryonic development and cell cycle progression S Mohibi, CB Gurumurthy, A Nag, J Wang, S Mirza, Y Mian, M Quinn, ... Journal of Biological Chemistry 287 (35), 29442-29456, 2012 | 40 | 2012 |